GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Aoki, T.  (2)
Material
Publisher
Language
Years
Subjects(RVK)
  • 1
    In: Allergy, Wiley, Vol. 73, No. 5 ( 2018-05), p. 1110-1118
    Abstract: Reducing near‐fatal asthma exacerbations is a critical problem in asthma management. Objectives To determine patterns of factors preceding asthma exacerbations in a real‐world setting. Methods In a nationwide prospective study of 190 patients who had experienced near‐fatal asthma exacerbation, cluster analysis was performed using asthma symptoms over the 2‐week period before admission. Results Three distinct clusters of symptoms were defined employing the self‐reporting of a visual analogue scale. Cluster A (42.1%): rapid worsening within 7.4 hours from moderate attack to admission, young to middle‐aged patients with low Body mass index and tendency to depression who had stopped anti‐asthma medications, smoked, and hypersensitive to environmental triggers and furred pets. Cluster B (40.0%): fairly rapid worsening within 48 hours, mostly middle‐aged and older, relatively good inhaled corticosteroid ( ICS ) or ICS /long‐acting beta‐agonist ( LABA ) compliance, and low perception of dyspnea. Cluster C (17.9%): slow worsening over 10 days before admission, high perception of dyspnea, smokers, and chronic daily mild‐moderate symptoms. There were no differences in overuse of short‐acting beta‐agonists, baseline asthma severity, or outcomes after admission for patients in these 3 clusters. Conclusion To reduce severe or life‐threatening asthma exacerbation, personalized asthma management plans should be considered for each cluster. Improvement of ICS and ICS / LABA compliance and cessation of smoking are important in cluster A. To compensate for low perception of dyspnea, asthma monitoring of peak expiratory flow rate and/or exhaled nitric oxide would be useful for patients in cluster B. Avoidance of environmental triggers, increase usual therapy, or new anti‐type 2 response‐targeted therapies should be considered for cluster C.
    Type of Medium: Online Resource
    ISSN: 0105-4538 , 1398-9995
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2018
    detail.hit.zdb_id: 2003114-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Clinical & Experimental Allergy, Wiley, Vol. 46, No. 8 ( 2016-08), p. 1043-1055
    Abstract: Severe or life‐threatening asthma exacerbation is one of the worst outcomes of asthma because of the risk of death. To date, few studies have explored the potential heterogeneity of this condition. Objectives To examine the clinical characteristics and heterogeneity of patients with severe or life‐threatening asthma exacerbation. Methods This was a multicentre, prospective study of patients with severe or life‐threatening asthma exacerbation and pulse oxygen saturation 〈 90% who were admitted to 17 institutions across Japan. Cluster analysis was performed using variables from patient‐ and physician‐orientated structured questionnaires. Results Analysis of data from 175 patients with severe or life‐threatening asthma exacerbation revealed five distinct clusters. Cluster 1 ( n = 27) was younger‐onset asthma with severe symptoms at baseline, including limitation of activities, a higher frequency of treatment with oral corticosteroids and short‐acting beta‐agonists, and a higher frequency of asthma hospitalizations in the past year. Cluster 2 ( n = 35) was predominantly composed of elderly females, with the highest frequency of comorbid, chronic hyperplastic rhinosinusitis/nasal polyposis, and a long disease duration. Cluster 3 ( n = 40) was allergic asthma without inhaled corticosteroid use at baseline. Patients in this cluster had a higher frequency of atopy, including allergic rhinitis and furred pet hypersensitivity, and a better prognosis during hospitalization compared with the other clusters. Cluster 4 ( n = 34) was characterized by elderly males with concomitant chronic obstructive pulmonary disease ( COPD ). Although cluster 5 ( n = 39) had very mild symptoms at baseline according to the patient questionnaires, 41% had previously been hospitalized for asthma. Conclusions & Clinical Relevance This study demonstrated that significant heterogeneity exists among patients with severe or life‐threatening asthma exacerbation. Differences were observed in the severity of asthma symptoms and use of inhaled corticosteroids at baseline, and the presence of comorbid COPD . These findings may contribute to a deeper understanding and better management of this patient population.
    Type of Medium: Online Resource
    ISSN: 0954-7894 , 1365-2222
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2016
    detail.hit.zdb_id: 2186232-1
    detail.hit.zdb_id: 2004469-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...